Google快讯 - lung cancer

	lung cancer 实时更新 ⋅ 2026年7月9日
	新闻
	Ensartinib in Resected ALK-Positive Non–Small-Cell Lung Cancer The New England Journal of Medicine Anaplastic lymphoma kinase (ALK) inhibitors have emerged as promising agents for patients with resectable ALK-positive non–small-cell lung cancer ... 标记为不相关
	Lung Transplant for Refractory Lung-Limited Stage IV Non–Small Cell Lung Cancer JAMA Network All patients who underwent lung transplant exhibited respiratory failure (306 without cancer underwent lung transplant for end-stage pulmonary disease); ... 标记为不相关
	Ensartinib in Resected ALK-Positive Non-Small-Cell Lung Cancer - PubMed PubMed Division of Thoracic Tumor Multimodality Treatment and Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu ... 标记为不相关
	FAK co-inhibition in KRAS G12C -mutated non-small-cell lung cancer - The Lancet The Lancet ... lung cancer (NSCLC). 1. Riedl, JM ∙ Matsubara, H ∙ McNeil, R ∙ et al. Emerging landscape of KRAS inhibitors in cancer treatment. Cancer Cell. 标记为不相关
	Case 3: Second-Line Treatment of Extensive-Stage Small Cell Lung Cancer The ASCO Post ... Lung Cancer Spectrum, an ASCO Post Roundtable. I'm Dr. Laura Alder. I'm an Assistant Professor in thoracic medical oncology at Duke Cancer ... 标记为不相关
	Predicting T790M mutation status in non-small cell lung cancer based on radiomics Research journals - PLOS Therefore, assessing EGFR T790M mutation status during non-small cell lung cancer (NSCLC) treatment is crucial for improving NSCLC prognosis. Method. 标记为不相关
	Study Hints at Survival Benefit With Transplant for Metastatic Lung Cancer | MedPage Today MedPage Today Survival in the transplant group was also similar to a cohort of non-cancer patients who underwent lung transplantation for end-stage pulmonary ... 标记为不相关
	Case 1: Limited-Stage Small Cell Lung Cancer - The ASCO Post The ASCO Post Case 1: Limited-Stage Small Cell Lung Cancer. Posted: 07/13/2026. This is Part 1 of Integrating Immunotherapy Across the SCLC Spectrum, a three-part ... 标记为不相关
	AR-guided localization may sub for CT for early-stage lung cancer | AuntMinnie AuntMinnie Augmented reality (AR)-guided percutaneous localization could achieve successful sublobar resection in early-stage lung cancer patients, ... 标记为不相关
	Study backs LDCT lung cancer screening in Singapore | AuntMinnie AuntMinnie Lung cancer is the leading cause of cancer death in Singapore, with approximately 48% of cases occurring in individuals who have never smoked. 标记为不相关
查看更多结果 | 修改此快讯

您收到此电子邮件是因为您订阅了Google快讯。 退订 | 查看您所有的快讯

以RSS Feed的形式接收此快讯

发送反馈